Publication & Citation Trends
Publications
0 total
Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trial
Cited by 1
Semantic Scholar
A Phase 3 Trial of Brepocitinib in Dermatomyositis
Cited by 0
Semantic Scholar
Fixed Cycle and Every-Other-Week Dosing of Intravenous Efgartigimod for Generalized Myasthenia Gravis: Part B of ADAPT NXT (P1-11.004)
Cited by 1
Semantic Scholar
3390 Effect of zilucoplan on myasthenia gravis-specific outcome subdomain scores in RAISE: a phase 3 study
Cited by 0
Semantic Scholar
Impact of patisiran on polyneuropathy of hereditary transthyretin amyloidosis in patients with a V122I or T60A variant: a phase IV multicenter study
Cited by 0
Semantic Scholar
ADAPT NXT: Fixed Cycles or Every‐Other‐Week IV Efgartigimod in Generalized Myasthenia Gravis OA
Cited by 10
Semantic Scholar
Efficacy and safety of efgartigimod PH20 subcutaneously (sc) in chronic inflammatory demyelinating polyneuropathy (CIDP): results from the ADHERE/ADHERE+ studies
Cited by 0
Semantic Scholar
Effect of Zilucoplan on Myasthenia Gravis–Specific Outcome Subdomain Scores in RAISE: A Phase 3 Study (S34.004)
Cited by 0
Semantic Scholar
Research Topics
Myasthenia Gravis and Thymoma
(21)
Peripheral Neuropathies and Disorders
(12)
Parkinson's Disease and Spinal Disorders
(11)
Cancer Treatment and Pharmacology
(9)
COVID-19 Clinical Research Studies
(5)
Affiliations
University of Siena
Austin College
Apple (Israel)
Hospital of the University of Pennsylvania
Colorado Springs Neurological Associates